Amicus

Overview

Amicus Therapeutics UK Limited is a biotechnology company focused on discovering, developing, and delivering medicines for rare metabolic diseases. It operates as part of a global patient-dedicated biotechnology effort, with its UK entity maintaining active status and significant financial operations including turnover over £54M. The company is certified as a great place to work by 83% of its employees, higher than the UK average.

History

Amicus Therapeutics UK Limited was incorporated on 19 August 2005 as a private limited company. It is a subsidiary of the global Amicus Therapeutics (Nasdaq: FOLD), which focuses on rare metabolic diseases. No specific founders or key milestones for the UK entity are detailed in available records.

Reputation

83% of employees rate it as a great place to work, compared to 54% at typical UK companies. It is perceived positively in the biotechnology sector for its focus on rare diseases. No specific criticisms from enthusiasts or professionals are noted in available sources.

Sources (9)

1. https://find-and-update.company-information.service.gov.uk/company/05541527
2. https://open.endole.co.uk/insight/company/05541527-amicus-therapeutics-uk-limited
3. https://www.greatplacetowork.co.uk/certified-company/1570016
4. https://find-and-update.company-information.service.gov.uk/company/03879859
5. https://www.amicusrx.co.uk/about-us/who-we-are
6. https://www.companiesintheuk.co.uk/ltd/amicus-therapeutics-uk
7. https://www.amicusrx.co.uk
8. https://www.zoominfo.com/c/amicus-therapeutics-inc/1207357780
9. https://find-and-update.company-information.service.gov.uk/company/11128523/filing-history